Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA) A*02:01 positive patients with unresectable or metastatic uveal melanoma. Update May 2022

Rothschedl, E. and Wolf, S. (2022): Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA) A*02:01 positive patients with unresectable or metastatic uveal melanoma. Update May 2022. Oncology Fact Sheet Nr. 79.

[thumbnail of Oncology Fact Sheet Nr.79_Update.pdf]

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
104kB

Item Type:	Oncology Fact Sheet
Subjects:	QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WW Ophthalmology > WW 101-170 Eye
Language:	English
Series Name:	Oncology Fact Sheet Nr. 79
Deposited on:	28 Mar 2022 12:34
Last Modified:	24 May 2022 10:34

Repository Staff Only: item control page